with amphotericin B was started. On day 7, fungal species were isolated from the peritoneal catheter. Plasma BDG was 523 pg/mL, and the GM index was 1.05. Computed tomography imaging of thorax and abdomen revealed no pathology. On day 10, A. niger was isolated from the Tenckhoff catheter culture, with sensitivity to amphotericin B.
Filamentous fungi have only rarely been identified as causative agents in peritonitis complicating CAPD. The types of filamentous fungi reported to have caused CAPDrelated peritonitis include Aspergillus, Paecilomyces, Penicillium, Acrimonies, Fusarium, and Zygomycetes (2). In most peritonitis cases caused by Aspergillus, the causative agent has been found to be A. fumigatus, A. terreus, A. flavus, or A. niger. Peritoneal dialysis-related peritonitis caused by A. niger has been described 5 times previously in the literature (3, 4, 5) .
Despite the availability of newer antifungal drugs, outcomes in patients with invasive fungal infections continue to be poor because of delayed diagnosis and initiation of appropriate antifungal therapy. Diagnosis of invasive aspergillosis is even more difficult. Standard histopathologic diagnostic techniques and culture-based diagnostics typically take too long to allow for optimal treatment. Newer surrogate markers of invasive fungal infection are needed to hasten diagnosis and permit therapeutic monitoring. Clinicians have recently been using several adjunctive methods, such as GM antigen detection or BDG assay.
Galactomannan is a component of the Aspergillus species cell wall that is released into the surrounding environment during fungal growth or tissue invasion (6) . In 2003, the US Food and Drug Administration approved the use of a double-sandwich GM enzyme immunoassay (Platelia Aspergillus EIA: Bio-Rad Laboratories) for the diagnosis of invasive aspergillosis in adult patients (7) . The double-sandwich ELISA for detection of GM is reported to have high sensitivity and high specify for invasive aspergillosis when a cut-off value of 0.8 ng/mL is used (8) .
The polysaccharide BDG is located in the cell membrane of most fungal pathogens, notable exceptions being Mucor and Cryptococcus species (6, 9) . Small quantities of β-glucan are released into blood during an invasive fungal infection, and the Fungitell Assay can detect β-glucan in serum, providing results within 2 hours (10) . A number of commercially available methods use various methodologies, cut-off values, and sensitivities to detect BG. The chromogenic BDG test (Fungitell Assay) was approved by the Food and Drug Administration as an adjunct (6) . The assay uses a blood coagulation PDI factor (factor G) isolated from blood cells of the North American horseshoe crab to selectively detect β-glucan in a colorimetric assay (6, 10 ). An important study by a group of Japanese researchers, which appeared in The lancet in 1995, demonstrated high sensitivity (90%), specificity (100%), and negative predictive value (97%) for invasive mycosis with the use of a BDG assay and a plasma cut-off value of 20 pg/mL in febrile patients (11) . The present report suggests that the BDG assay and GM index previously suggested as useful in the management of invasive fungal infections in neutropenic hematologic patients may be suitable for application in the early diagnosis of fungal peritonitis.
DISCLOSURES
